Nua secures $50 million in Series C funding to expand its women's wellness platform.
Indian femtech startup Nua has successfully closed a $50 million (approximately ₹472 Cr) Series C funding round. The investment was led by Peak XV Partners and Filter Capital, with continued participation from existing investors Mirabilis Investment Trust and Footpath Ventures.
The financing structure included a combination of primary capital infusion and secondary transactions, which provided partial exits for early investors, including Kae Capital and Lightbox VC. This latest injection brings Nua’s total historical funding to over $65 million.
Founded in 2017, Nua has evolved from a niche menstrual care brand into a broader women’s wellness platform. The company’s portfolio now spans period care, skincare, and nutritional supplements. According to the company, the fresh capital will be directed toward brand development, the expansion of its distribution footprint, and enhanced R&D efforts to diversify its product pipeline.
Nua’s growth trajectory highlights the increasing investor appetite for India’s femtech sector. CEO Ravi Ramachandran reported that the company’s annualized revenue run rate has grown fivefold over the past 24 months, reaching ₹500 Cr while maintaining profitability. The firm currently serves an estimated 3 million users monthly through its direct-to-consumer website and various third-party e-commerce and quick-commerce channels.
The broader market for women’s health technology in India is undergoing rapid maturation. Sector forecasts from the IMARC Group suggest a compound annual growth rate (CAGR) of 15.7% through 2034, projecting a market size of $5.5 billion. Nua’s latest funding round follows similar capital activity in the space, including recent investments into competitors such as Pee Safe and Healthfab, signaling a consolidation and scaling phase for D2C wellness brands in the region.
About the Author
